Private Advisor Group, LLC Nu Cana PLC Transaction History

Private Advisor Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$0.7 - $0.96 $1,400 - $1,920	2,000 Added 14.81%	15,500 $12,000
Q1 2023 May 10, 2023	BUY	$0.76 - $1.69 $10,260 - $22,815	13,500 New	13,500 $12,000
Q3 2022 Oct 14, 2022	BUY	$0.62 - $26.13 $10,850 - $457,275	17,500 New	17,500 $18,000
Q2 2022 Jul 13, 2022	SELL	$0.59 - $1.06 $16,667 - $29,945	-28,250 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.74 - $3.27 $13,912 - $61,476	-18,800 Reduced 39.96%	28,250 $28,000
Q4 2021 Feb 10, 2022	BUY	$2.02 - $2.9 $95,041 - $136,445	47,050 New	47,050 $112,000
Q3 2020 Nov 02, 2020	SELL	$4.57 - $6.48 $1,828 - $2,592	-400 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$4.87 - $7.37 $1,948 - $2,948	400 New	400 $2,000

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $64.2M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.